Miglustat Dipharma, caps 100 mg , blist 84 pce (ancien)
7680676330019
CH-67633
A16AX06
Reimbursement limitations:
ZAVESCA
Pour le traitement des patients adultes atteints d'une maladie de Gaucher de type 1 dans …
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
100.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | FTODK |
Reimbursement information
Public price
CHF 4422.00
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/11/2020
Authorization holder
Dipharma SA
6830 Chiasso
Authorization information
- Swissmedic authorization number
- 67633
- Drug name
- Miglustat Dipharma, capsule
- Galenic form
- KAHA
- ATC Code
- A16AX06
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 03/04/2020
- Authorization expiration date
- 31/12/9999
- IT number
- 07.99.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- MIGLUSTAT Dipharma caps 100 mg blist 84 pce
- Description (DE)
- MIGLUSTAT Dipharma Kaps 100 mg Blist 84 Stk
- Narcotic (BTM)
- No